JP2020534270A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020534270A5 JP2020534270A5 JP2020514950A JP2020514950A JP2020534270A5 JP 2020534270 A5 JP2020534270 A5 JP 2020534270A5 JP 2020514950 A JP2020514950 A JP 2020514950A JP 2020514950 A JP2020514950 A JP 2020514950A JP 2020534270 A5 JP2020534270 A5 JP 2020534270A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- sleep
- effective amount
- composition
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023008782A JP2023038310A (ja) | 2017-09-14 | 2023-01-24 | １９－ノルｃ３，３－二置換ｃ２１－ｎ－ピラゾリルステロイドおよびその使用方法 |
| JP2024091642A JP2024107137A (ja) | 2017-09-14 | 2024-06-05 | １９－ノルｃ３，３－二置換ｃ２１－ｎ－ピラゾリルステロイドおよびその使用方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762558703P | 2017-09-14 | 2017-09-14 | |
| US62/558,703 | 2017-09-14 | ||
| US201862624678P | 2018-01-31 | 2018-01-31 | |
| US201862624680P | 2018-01-31 | 2018-01-31 | |
| US62/624,678 | 2018-01-31 | ||
| US62/624,680 | 2018-01-31 | ||
| US201862653189P | 2018-04-05 | 2018-04-05 | |
| US62/653,189 | 2018-04-05 | ||
| PCT/US2018/051048 WO2019055764A1 (en) | 2017-09-14 | 2018-09-14 | C21-N-PYRAZOLYL C3,3-DISUBSTITUTED STEROID 19 NOR, AND METHODS OF USING THE SAME |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023008782A Division JP2023038310A (ja) | 2017-09-14 | 2023-01-24 | １９－ノルｃ３，３－二置換ｃ２１－ｎ－ピラゾリルステロイドおよびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020534270A JP2020534270A (ja) | 2020-11-26 |
| JP2020534270A5 true JP2020534270A5 (https=) | 2021-10-28 |
Family
ID=65723895
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020514950A Pending JP2020534270A (ja) | 2017-09-14 | 2018-09-14 | １９−ノルｃ３，３−二置換ｃ２１−ｎ−ピラゾリルステロイドおよびその使用方法 |
| JP2023008782A Pending JP2023038310A (ja) | 2017-09-14 | 2023-01-24 | １９－ノルｃ３，３－二置換ｃ２１－ｎ－ピラゾリルステロイドおよびその使用方法 |
| JP2024091642A Pending JP2024107137A (ja) | 2017-09-14 | 2024-06-05 | １９－ノルｃ３，３－二置換ｃ２１－ｎ－ピラゾリルステロイドおよびその使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023008782A Pending JP2023038310A (ja) | 2017-09-14 | 2023-01-24 | １９－ノルｃ３，３－二置換ｃ２１－ｎ－ピラゾリルステロイドおよびその使用方法 |
| JP2024091642A Pending JP2024107137A (ja) | 2017-09-14 | 2024-06-05 | １９－ノルｃ３，３－二置換ｃ２１－ｎ－ピラゾリルステロイドおよびその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20220110949A1 (https=) |
| EP (3) | EP4218767A1 (https=) |
| JP (3) | JP2020534270A (https=) |
| AU (2) | AU2018334214A1 (https=) |
| CA (1) | CA3075872A1 (https=) |
| IL (2) | IL303083A (https=) |
| MX (3) | MX2020002889A (https=) |
| TW (2) | TW202339764A (https=) |
| WO (1) | WO2019055764A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2806877B2 (en) | 2012-01-23 | 2025-01-29 | Sage Therapeutics, Inc. | Neuroactive steroid formulations comprising a complex of allopregnanolone and sulfobutyl ether beta-cyclodextrin |
| CA2882708A1 (en) | 2012-08-21 | 2014-02-27 | Sage Therapeutics, Inc. | Methods of treating epilepsy or status epilepticus |
| KR102396328B1 (ko) | 2013-04-17 | 2022-05-10 | 세이지 테라퓨틱스, 인크. | 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법 |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| WO2016082789A1 (en) | 2014-11-27 | 2016-06-02 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| EP3504189A1 (en) | 2016-08-23 | 2019-07-03 | Sage Therapeutics, Inc. | A crystalline 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroid |
| MA51046A (fr) | 2017-12-08 | 2021-03-17 | Sage Therapeutics Inc | Dérivés de 21-[4-cyano-pyrazol-1-yl]-19-nor-pregan-3. alpha-ol-20-one deutérés pour le traitement de troubles du snc |
| US10857163B1 (en) | 2019-09-30 | 2020-12-08 | Athenen Therapeutics, Inc. | Compositions that preferentially potentiate subtypes of GABAA receptors and methods of use thereof |
| KR20220112803A (ko) * | 2019-12-05 | 2022-08-11 | 세이지 테라퓨틱스, 인크. | 19-nor c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102396328B1 (ko) * | 2013-04-17 | 2022-05-10 | 세이지 테라퓨틱스, 인크. | 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법 |
| ME03809B (me) * | 2014-10-16 | 2021-04-20 | Sage Therapeutics Inc | KOMPOZICIJE I POSTUPCI ZA LEČENJE POREMEĆAJA CNS-a |
| EP3504189A1 (en) * | 2016-08-23 | 2019-07-03 | Sage Therapeutics, Inc. | A crystalline 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroid |
| WO2019051264A1 (en) * | 2017-09-07 | 2019-03-14 | Sage Therapeutics, Inc. | NEUROACTIVE STEROIDS AND METHODS OF USE |
-
2018
- 2018-09-14 CA CA3075872A patent/CA3075872A1/en active Pending
- 2018-09-14 AU AU2018334214A patent/AU2018334214A1/en not_active Abandoned
- 2018-09-14 EP EP23150618.9A patent/EP4218767A1/en not_active Withdrawn
- 2018-09-14 JP JP2020514950A patent/JP2020534270A/ja active Pending
- 2018-09-14 IL IL303083A patent/IL303083A/en unknown
- 2018-09-14 TW TW111150395A patent/TW202339764A/zh unknown
- 2018-09-14 EP EP18786464.0A patent/EP3681510A1/en not_active Withdrawn
- 2018-09-14 WO PCT/US2018/051048 patent/WO2019055764A1/en not_active Ceased
- 2018-09-14 EP EP25207758.1A patent/EP4696301A3/en active Pending
- 2018-09-14 MX MX2020002889A patent/MX2020002889A/es unknown
- 2018-09-14 US US16/647,203 patent/US20220110949A1/en not_active Abandoned
- 2018-09-14 TW TW107132510A patent/TW201919642A/zh unknown
-
2020
- 2020-03-08 IL IL273126A patent/IL273126A/en unknown
- 2020-03-13 MX MX2023010063A patent/MX2023010063A/es unknown
- 2020-03-13 MX MX2023010064A patent/MX2023010064A/es unknown
-
2023
- 2023-01-24 JP JP2023008782A patent/JP2023038310A/ja active Pending
- 2023-03-01 US US18/176,571 patent/US20230201224A1/en not_active Abandoned
-
2024
- 2024-06-05 JP JP2024091642A patent/JP2024107137A/ja active Pending
- 2024-08-07 AU AU2024205601A patent/AU2024205601A1/en active Pending
-
2025
- 2025-05-08 US US19/202,525 patent/US20250387414A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020534270A5 (https=) | ||
| JP2022191257A5 (https=) | ||
| JP2021527092A5 (https=) | ||
| EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
| JP2014139255A5 (https=) | ||
| JP2015526458A5 (https=) | ||
| JP2018520189A5 (https=) | ||
| CN106999467A (zh) | 治疗认知减退的方法 | |
| JP2016515628A5 (https=) | ||
| RU2014150942A (ru) | Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона | |
| RU2010142456A (ru) | Синергические комбинации 5'-метилтиоаденозина | |
| JP2021152060A (ja) | アカンプロセートおよびｄ−サイクロセリンを使用する組み合わせ療法 | |
| JP2024515829A5 (https=) | ||
| JP2017533220A5 (https=) | ||
| JP2024512425A5 (https=) | ||
| EP4520394A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| JP2013536837A5 (https=) | ||
| JP2015522077A5 (https=) | ||
| JP2023553253A5 (https=) | ||
| RU2008134143A (ru) | Фармацевтическая композиция цитиколина, холина альфосцерата и l-карнитина (или ацетил-l-карнитина) для лечения и профилактики заболеваний центральной нервной системы и способ лечения | |
| RU2020120876A (ru) | Фармацевтическая композиция, содержащая антагонист минералокортикоидных рецепторов, и ее применение | |
| JP2018529747A5 (https=) | ||
| RU2006131553A (ru) | Комбинация(а) ингибитора топоизомеразы днк и (б) ингибитора iap | |
| JP2019512507A5 (https=) | ||
| JP2022505184A5 (https=) |